295 related articles for article (PubMed ID: 30738608)
1. Quantification of doxorubicin-induced interstitial myocardial fibrosis in a beagle model using equilibrium contrast-enhanced computed tomography: A comparative study with cardiac magnetic resonance T1-mapping.
Zhou Z; Xu L; Wang R; Varga-Szemes A; Durden JA; Joseph Schoepf U; Sun Z; Fan Z
Int J Cardiol; 2019 Apr; 281():150-155. PubMed ID: 30738608
[TBL] [Abstract][Full Text] [Related]
2. Myocardial Characterization Using Dual-Energy CT in Doxorubicin-Induced DCM: Comparison With CMR T1-Mapping and Histology in a Rabbit Model.
Hong YJ; Kim TK; Hong D; Park CH; Yoo SJ; Wickum ME; Hur J; Lee HJ; Kim YJ; Suh YJ; Greiser A; Paek MY; Choi BW
JACC Cardiovasc Imaging; 2016 Jul; 9(7):836-845. PubMed ID: 27236517
[TBL] [Abstract][Full Text] [Related]
3. Quantification of diffuse myocardial fibrosis using CMR extracellular volume fraction and serum biomarkers of collagen turnover with histologic quantification as standard of reference.
Foussier C; Barral PA; Jerosh-Herold M; Gariboldi V; Rapacchi S; Gallon A; Bartoli A; Bentatou Z; Guye M; Bernard M; Jacquier A
Diagn Interv Imaging; 2021 Mar; 102(3):163-169. PubMed ID: 32830084
[TBL] [Abstract][Full Text] [Related]
4. Myocardial extracellular volume fraction quantification in an animal model of the doxorubicin-induced myocardial fibrosis: a synthetic hematocrit method using 3T cardiac magnetic resonance.
Zhou Z; Wang R; Wang H; Liu Y; Lu D; Sun Z; Yang G; Xu L
Quant Imaging Med Surg; 2021 Feb; 11(2):510-520. PubMed ID: 33532252
[TBL] [Abstract][Full Text] [Related]
5. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
White SK; Sado DM; Fontana M; Banypersad SM; Maestrini V; Flett AS; Piechnik SK; Robson MD; Hausenloy DJ; Sheikh AM; Hawkins PN; Moon JC
JACC Cardiovasc Imaging; 2013 Sep; 6(9):955-62. PubMed ID: 23582361
[TBL] [Abstract][Full Text] [Related]
6. Extracellular volume quantitation using dual-energy CT in patients with heart failure: Comparison with 3T cardiac MR.
Wang R; Liu X; Schoepf UJ; van Assen M; Alimohamed I; Griffith LP; Luo T; Sun Z; Fan Z; Xu L
Int J Cardiol; 2018 Oct; 268():236-240. PubMed ID: 29804697
[TBL] [Abstract][Full Text] [Related]
7. Myocardial extracellular volume fraction analysis in doxorubicin-induced beagle models: comparison of dual-energy CT with equilibrium contrast-enhanced single-energy CT.
Zhou Z; Gao Y; Wang H; Wang W; Zhang H; Wang S; Sun Z; Xu L
Cardiovasc Diagn Ther; 2021 Feb; 11(1):102-110. PubMed ID: 33708482
[TBL] [Abstract][Full Text] [Related]
8. Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.
Ide S; Riesenkampff E; Chiasson DA; Dipchand AI; Kantor PF; Chaturvedi RR; Yoo SJ; Grosse-Wortmann L
J Cardiovasc Magn Reson; 2017 Feb; 19(1):10. PubMed ID: 28143545
[TBL] [Abstract][Full Text] [Related]
9. Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation.
Cui Y; Cao Y; Song J; Dong N; Kong X; Wang J; Yuan Y; Zhu X; Yan X; Greiser A; Shi H; Han P
J Cardiovasc Magn Reson; 2018 Apr; 20(1):25. PubMed ID: 29681243
[TBL] [Abstract][Full Text] [Related]
10. Myocardial Extracellular Volume Fraction with Dual-Energy Equilibrium Contrast-enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MR Imaging.
Lee HJ; Im DJ; Youn JC; Chang S; Suh YJ; Hong YJ; Kim YJ; Hur J; Choi BW
Radiology; 2016 Jul; 280(1):49-57. PubMed ID: 27322972
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis).
Liu CY; Liu YC; Wu C; Armstrong A; Volpe GJ; van der Geest RJ; Liu Y; Hundley WG; Gomes AS; Liu S; Nacif M; Bluemke DA; Lima JAC
J Am Coll Cardiol; 2013 Oct; 62(14):1280-1287. PubMed ID: 23871886
[TBL] [Abstract][Full Text] [Related]
12. Myocardial extracellular volume quantification in cardiac amyloidosis: a comparative study between cardiac computed tomography and magnetic resonance imaging.
Hayashi H; Oda S; Kidoh M; Yamaguchi S; Yoshimura F; Takashio S; Usuku H; Nagayama Y; Nakaura T; Ueda M; Tsujita K; Hirai T
Eur Radiol; 2024 Feb; 34(2):1016-1025. PubMed ID: 37597032
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.
Dolan RS; Stillman AE; Davarpanah AH
Acad Radiol; 2022 Apr; 29 Suppl 4():S100-S109. PubMed ID: 34702675
[TBL] [Abstract][Full Text] [Related]
14. Quantitating myocardial fibrosis using extracellular extravascular volume determined from computed tomography myocardial perfusion imaging.
Li N; Zhang X; Gu J; Yang M; Chen L; Yu J; Shi H
BMC Med Imaging; 2024 Feb; 24(1):40. PubMed ID: 38347469
[TBL] [Abstract][Full Text] [Related]
15. Quantification of Early Diffuse Myocardial Fibrosis Through 7.0 T Cardiac Magnetic Resonance T1 Mapping in a Type 1 Diabetic Mellitus Mouse Model.
Zhang H; Shi C; Yang L; Zhang N; Li G; Zhou Z; Gao Y; Liu D; Xu L; Fan Z
J Magn Reson Imaging; 2023 Jan; 57(1):167-177. PubMed ID: 35436040
[TBL] [Abstract][Full Text] [Related]
16. Automatic quantification of the myocardial extracellular volume by cardiac computed tomography: Synthetic ECV by CCT.
Treibel TA; Fontana M; Steeden JA; Nasis A; Yeung J; White SK; Sivarajan S; Punwani S; Pugliese F; Taylor SA; Moon JC; Bandula S
J Cardiovasc Comput Tomogr; 2017; 11(3):221-226. PubMed ID: 28268091
[TBL] [Abstract][Full Text] [Related]
17. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
[TBL] [Abstract][Full Text] [Related]
18. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.
Fontana M; White SK; Banypersad SM; Sado DM; Maestrini V; Flett AS; Piechnik SK; Neubauer S; Roberts N; Moon JC
J Cardiovasc Magn Reson; 2012 Dec; 14(1):88. PubMed ID: 23272651
[TBL] [Abstract][Full Text] [Related]
19. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
[TBL] [Abstract][Full Text] [Related]
20. Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population.
Storz C; Hetterich H; Lorbeer R; Heber SD; Schafnitzel A; Patscheider H; Auweter S; Zitzelsberger T; Rathmann W; Nikolaou K; Reiser M; Schlett CL; von Knobelsdorff-Brenkenhoff F; Peters A; Schulz-Menger J; Bamberg F
Eur Heart J Cardiovasc Imaging; 2018 Jun; 19(6):701-708. PubMed ID: 28950340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
